Cited by 57Alzheimer's disease research and treatmentsLipid Membrane Structure and BehaviorCholesterol and Lipid Metabolism

Dissociation of Apolipoprotein E Oligomers to Monomer Is Required for High-Affinity Binding to Phospholipid Vesicles

Open access
Kanchan Garai, Berevan A. Baban, Carl Frieden·2011·Biochemistry

Abstract

The apolipoprotein apoE plays a key role in cholesterol and lipid metabolism. There are three isoforms of this protein, one of which, apoE4, is the major risk factor for Alzheimer's disease. At micromolar concentrations all lipid-free apoE isoforms exist primarily as monomers, dimers, and tetramers. However, the molecular weight form of apoE that binds to lipid has not been clearly defined. We have examined the role of self-association of apoE with respect to interactions with phospholipids. Measurements of the time dependence of turbidity clearance of small unilamellar vesicles of dimyristoyl-sn-glycero-3-phosphocholine (DMPC) upon addition of apoE show that higher molecular weight oligomers bind poorly if at all. The kinetic data can be described by a reaction model in which tetramers and dimers of apoE must first dissociate to monomers which then bind to the liposome surface in a fast and reversible manner. A slow but not readily reversible conformational conversion of the monomer then occurs. Prior knowledge of the rate constants for the association-dissociation process allows us to determine the rate constant of the conformational conversion. This rate constant is isoform dependent and appears to correlate with the stability of the apoE isoforms with the rate of dissociation of the apoE oligomers to monomers being the rate-limiting process for lipidation. Differences in the lipidation kinetics between the apoE isoforms arise from their differences in the self-association behavior leading to the conclusion that self-association behavior may influence biological functions of apoE in an isoform-dependent manner.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

OpenAlex · 10.1021/bi1020106

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • An antibody against non-lipidated APOE, which is the version most likely to oligomerize, has shown promise in multiple Alzheimer disease mouse models.

    “Along this line, an antibody against non-lipidated APOE, which is the version most likely to oligomerize, has shown promise in multiple AD mouse models136–139.”

    From Multifaceted roles of APOE in Alzheimer disease (2024) · cites this paper as [136]

    The Abstract (page unavailable) reports that lipid-free apoE forms monomers, dimers, and tetramers, supporting the oligomerization part of the sentence. The paper studies apoE binding to phospholipid vesicles; it does not report an antibody treatment or results in Alzheimer disease mouse models. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Only the monomer of ApoE is able to bind lipids, and lipidated ApoE appears to be protected from aggregation.

    “However only the monomer of ApoE is able to bind lipids and lipidated ApoE appears to be protected from aggregation highlighting this as an important element of ApoE biology for further study (17,18).”

    From APOE Isoform-Dependent Self-Association Measured by a Split-Luciferase Complementation Assay: Differential Effects of Disease-Risk and Protective Variants (2026) · cites this paper as [18]

    The Discussion section, “Only monomer binds to lipids” (page unavailable), says monomers bind tightly and oligomer dissociation is necessary to form final lipoprotein particles. It also allows that dimers or higher oligomers may bind, so the claim that only monomers can bind lipids is too absolute. The paper discusses self-association of lipid-free apoE but does not establish that lipidated apoE is protected from aggregation. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Dissociation of apoE oligomers to monomers appears to be required for lipid binding to the protein.

    “Imperatively, the aggregation propensity of apoE likely influences its lipidation capacity (22), as dissociation of apoE oligomers to monomers appears to be required for lipid binding to the protein (46).”
  • Dissociation to monomer is thought to be required for high-affinity lipid binding and may influence downstream receptor interactions, making the non-covalent oligomeric pool the relevant target for understanding isoform-dependent differences in ApoE lipidation and cholesterol transport.

    “This form of self-association is functionally significant because dissociation to monomer is thought to be required for high-affinity lipid binding (18) and may influence downstream receptor interactions, making the non-covalent oligomeric pool the relevant target for understanding isoform-dependent differences in ApoE lipidation and cholesterol transport.”
  • ApoE lipidation shifts the monomer-oligomer equilibrium towards monomer.

    “ApoE lipidation is known to shift the monomeroligomer equilibrium towards monomer (18,24,35)”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 43

  1. [1]Weisgraber KH Innerarity TL Mahley RW Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site J Biol Chem 1982 257 2518 2521 6277903
  2. [5]Mahley RW Huang Y Rall SC Jr. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes J Lipid Res 1999 40 1933 1949 10552997
  3. [6]Getz GS Reardon CA Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall J Lipid Res 2009 50 Suppl S156 161 19018038 PMC2674757
  4. [8]Heide S Manfred K Glaser C Schulz S Apolipoprotein E (apoE) polymorphism: a risk factor for fatal coronary sclerosis? Forensic Sci Int 2009 192 62 66 19733021
  5. [9]Vaisi-Raygani A Rahimi Z Nomani H Tavilani H Pourmotabbed T The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients Clin Biochem 2007 40 1150 1156 17689519
  6. [10]Winkler K Hoffmann MM Krane V Marz W Drechsler C Wanner C Apolipoprotein E genotype predicts cardiovascular endpoints in dialysis patients with type 2 diabetes mellitus Atherosclerosis 2010 208 197 202 19628211
  7. [11]Bennet AM Di Angelantonio E Ye Z Wensley F Dahlin A Ahlbom A Keavney B Collins R Wiman B de Faire U Danesh J Association of apolipoprotein E genotypes with lipid levels and coronary risk Jama 2007 298 1300 1311 17878422
  8. [12]Anuurad E Lu G Rubin J Pearson TA Berglund L ApoE genotype affects allele-specific apo[a] levels for large apo[a] sizes in African Americans: the Harlem-Basset Study J Lipid Res 2007 48 693 698 17172560
  9. [13]Wagle J Farner L Flekkoy K Wyller TB Sandvik L Eiklid KL Fure B Stensrod B Engedal K Association between ApoE epsilon4 and cognitive impairment after stroke Dement Geriatr Cogn Disord 2009 27 525 533 19494491
  10. [14]Corder EH Saunders AM Strittmatter WJ Schmechel DE Gaskell PC Small GW Roses AD Haines JL Pericak-Vance MA Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 1993 261 921 923 8346443
  11. [16]Farrer LA Cupples LA Haines JL Hyman B Kukull WA Mayeux R Myers RH Pericak-Vance MA Risch N van Duijn CM Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium Jama 1997 278 1349 1356 9343467
  12. [17]Alberts MJ Graffagnino C McClenny C DeLong D Strittmatter W Saunders AM Roses AD ApoE genotype and survival from intracerebral haemorrhage Lancet 1995 346 575 7658797
  13. [20]Sivashanmugam A Wang J A unified scheme for initiation and conformational adaptation of human apolipoprotein E N-terminal domain upon lipoprotein binding and for receptor binding activity J Biol Chem 2009 284 14657 14666 19307174 PMC2682913
  14. [23]Patel AB Khumsupan P Narayanaswami V Pyrene fluorescence analysis offers new insights into the conformation of the lipoprotein-binding domain of human apolipoprotein E Biochemistry 2010 49 1766 1775 20073510
  15. [24]Narayanaswami V Szeto SS Ryan RO Lipid association-induced N-and C-terminal domain reorganization in human apolipoprotein E3 J Biol Chem 2001 276 37853 37860 11483594
  16. [25]Hatters DM Budamagunta MS Voss JC Weisgraber KH Modulation of apolipoprotein E structure by domain interaction: differences in lipid-bound and lipid-free forms J Biol Chem 2005 280 34288 34295 16076841
  17. [26]Zhang Y Chen J Wang J A complete backbone spectral assignment of lipid-free human apolipoprotein E (apoE) Biomol NMR Assign 2008 2 207 210 19636906
  18. [27]Garai K Mustafi SM Baban B Frieden C Structural differences between apolipoprotein E3 and E4 as measured by (19)F NMR Protein Sci 2010 19 66 74 19904741 PMC2817840
  19. [28]Peters-Libeu CA Newhouse Y Hall SC Witkowska HE Weisgraber KH Apolipoprotein E*dipalmitoylphosphatidylcholine particles are ellipsoidal in solution J Lipid Res 2007 48 1035 1044 17308333
  20. [29]Schneeweis LA Koppaka V Lund-Katz S Phillips MC Axelsen PH Structural Analysis of Lipoprotein E Particles Biochemistry 2005 44 12525 12534 16156664
  21. [30]Segall ML Dhanasekaran P Baldwin F Anantharamaiah GM Weisgraber KH Phillips MC Lund-Katz S Influence of apoE domain structure and polymorphism on the kinetics of phospholipid vesicle solubilization J Lipid Res 2002 43 1688 1700 12364553
  22. [31]Massey JB Gotto AM Jr. Pownall HJ Human plasma high density apolipoprotein A-I: effect of protein-protein interactions on the spontaneous formation of a lipid-protein recombinant Biochem Biophys Res Commun 1981 99 466 474 6786293
  23. [32]Choy N Raussens V Narayanaswami V Inter-molecular coiled-coil formation in human apolipoprotein E C-terminal domain J Mol Biol 2003 334 527 539 14623192
  24. [33]Lund-Katz S Phillips MC High density lipoprotein structure-function and role in reverse cholesterol transport Subcell Biochem 51 183 227 20213545 PMC3215094
  25. [35]Garai K Frieden C The Association-Dissociation Behavior of the ApoE Proteins: Kinetic and Equilibrium Studies Biochemistry 2010 49 9533 9541 20923231 PMC3038193
  26. [36]Selvin PR Ha T Single-molecule techniques: a laboratory manual 2008 Cold Spring Harbor Laboratory Press Cold Spring Harbor, N.Y.
  27. [37]Santoro MM Bolen DW Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using different denaturants Biochemistry 1988 27 8063 8068 3233195
  28. [38]Johnson KA Simpson ZB Blom T Global kinetic explorer: a new computer program for dynamic simulation and fitting of kinetic data Anal Biochem 2009 387 20 29 19154726
  29. [39]Morjana NA McKeone BJ Gilbert HF Guanidine hydrochloride stabilization of a partially unfolded intermediate during the reversible denaturation of protein disulfide isomerase Proc Natl Acad Sci (USA) 1993 90 2107 2111 8460117 PMC46034
  30. [40]Pownall H Pao Q Hickson D Sparrow JT Kusserow SK Massey JB Kinetics and mechanism of association of human plasma apolipoproteins with dimyristoylphosphatidylcholine: effect of protein structure and lipid clusters on reaction rates Biochemistry 1981 20 6630 6635 7306528
  31. [41]Jonas A Drengler SM Kinetics and mechanism of apolipoprotein A-I interaction with L-alpha-dimyristoylphosphatidylcholine vesicles J Biol Chem 1980 255 2190 2194 7354087
  32. [42]Jonas A Drengler SM Patterson BW Two types of complexes formed by the interaction of apolipoprotein A-I with vesicles of L-alpha-dimyristoylphosphatidylcholine J Biol Chem 1980 255 2183 2189 7354086
  33. [43]Nguyen D Dhanasekaran P Phillips MC Lund-Katz S Molecular mechanism of apolipoprotein E binding to lipoprotein particles Biochemistry 2009 48 3025 3032 19209940 PMC2765560
  34. [44]Morrow JA Segall ML Lund-Katz S Phillips MC Knapp M Rupp B Weisgraber KH Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain Biochemistry 2000 39 11657 11666 10995233
  35. [45]Langer C Huang Y Cullen P Wiesenhutter B Mahley RW Assmann G von Eckardstein A Endogenous apolipoprotein E modulates cholesterol efflux and cholesteryl ester hydrolysis mediated by high-density lipoprotein-3 and lipid-free apolipoproteins in mouse peritoneal macrophages J Mol Med 2000 78 217 227 10933584
  36. [46]LaDu MJ Stine WB Narita M Getz GS Reardon CA Bu G Self-Assembly of HEK Cell-Secreted ApoE Particles Resembles ApoE Enrichment of Lipoproteins as a Ligand for the LDL Receptor-Related Protein Biochemistry 2006 45 381 390 16401069 PMC2564845
  37. [47]Krimbou L Denis M Haidar B Carrier M Marcil M Genest J Molecular interactions between apoE and ABCA1 J Lipid Res 2004 45 839 848 14754908
  38. [48]Weisgraber KH Rall SC Mahley RW Milne RW Marcel YL Sparrow JT Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3 J Biol Chem 1986 261 2068 2076 2418019
  39. [49]Lin C-Y Duan H Mazzone T Apolipoprotein E-dependent cholesterol efflux from macrophages: kinetic study and divergent mechanisms for endogenous versus exogenous apolipoprotein E J Lipid Res 1999 40 1618 1626 10484608
  40. [50]Bultel-Brienne S. p. Lestavel S Pilon A Laffont I Tailleux A Fruchart J-C Siest G. r. Clavey V. r. Lipid Free Apolipoprotein E Binds to the Class B Type I Scavenger Receptor I (SR-BI) and Enhances Cholesteryl Ester Uptake from Lipoproteins J Biol Chem 2002 277 36092 36099 12138091
  41. [51]Narita M Holtzman DM Fagan AM LaDu MJ Yu L Han X Gross RW Bu G Schwartz AL Cellular Catabolism of Lipid Poor Apolipoprotein E via Cell Surface LDL Receptor-Related Protein Journal of Biochemistry 2002 132 743 749 12417024
  42. [52]Ruiz J Kouiavskaia D Migliorini M Robinson S Saenko EL Gorlatova N Li D Lawrence D Hyman BT Weisgraber KH Strickland DK The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor J Lipid Res 2005 46 1721 1731 15863833
  43. [54]Neyen C Pluddemann A Roversi P Thomas B Cai L van der Westhuyzen DR Sim RB Gordon S Macrophage Scavenger Receptor A Mediates Adhesion to Apolipoproteins A-I and E Biochemistry 2009 48 11858 11871 19911804 PMC2793687

Cited by

Sorted by citations

Authors
Garai, K., Baban, B. A., & Frieden, C.
Affiliations
Washington University in St. Louis (US)
Corresponding author
Carl Frieden
Venue
Biochemistry
Published
2011-02-28
Volume
50
Issue
13
Pages
2550-2558
ISSN
  • 0006-2960 (ISSN-L)
  • 1520-4995
OpenAlex
W2020581548
Cited by
57
References
11
Citations by year
2026: 4 · 2025: 2 · 2024: 5 · 2023: 2 · 2022: 3 · 2021: 5 · 2020: 6 · 2019: 4 · 2018: 2 · 2017: 2 · 2016: 6 · 2014: 6 · 2013: 2 · 2012: 5
FWCI
3.49
Type
journal article
Language
en
Open access
Locations
  • Biochemistry (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Hope Center for Neurological Disorders
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK 13332, R01DK013332)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Lipid Membrane Structure and Behavior
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
Keywords
apolipoprotein E, APOE ε4, APOE isoforms, protein self-association, oligomer dissociation, lipid modification, phospholipid vesicles, distributed model predictive control, conformational conversion, binding kinetics, cholesterol metabolism
MeSH terms
Apolipoproteins E, Circular Dichroism, Dimyristoylphosphatidylcholine, Fluorescent Dyes, Humans, Kinetics, Osmolar Concentration, Protein Binding, Protein Denaturation, Dimerization, Protein Isoforms, Fluorescence Resonance Energy Transfer, Mutant Proteins, Apolipoprotein E4, Unilamellar Liposomes, Protein Stability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review